Status:
COMPLETED
A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.
Lead Sponsor:
Tongji Hospital
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
In the single-centered, retrospective study, 306 hospital patients (including 129 diabetes and 177 non-diabetes patients) confirmed with SARS-CoV-2 infection were enrolled in Tongji Hospital, Wuhan, C...
Eligibility Criteria
Inclusion
- Patients admitted from Feb 2, 2020 to Feb 15, 2020, diagnosed with SARS-CoV-2 pneumonia according to interim guidance of National health commission of the people's republic of China.
Exclusion
- With SARS-CoV-2 RNA detection negative results.
Key Trial Info
Start Date :
February 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT04365634
Start Date
February 2 2020
End Date
April 1 2020
Last Update
April 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, Hubei, China, 430030